Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years and older
Subjects must have a documented positive test for the SARS-CoV-2 infection within 7 days of randomization
Subject must be hospitalized within 72 hours of randomization
Subjects must be receiving standard of care for SARS-CoV-2
Subject/Legally Authorized Representative (LAR) must have the ability to understand and give informed consent
Subject must be able to take and absorb hydroxychloroquine at the discretion of the investigator
You may not be if
Prior receipt of hydroxychloroquine for treatment or prophylaxis of SARS-CoV-2 or patient is taking hydroxychloroquine for other approved indications (e.g., lupus, rheumatoid arthritis)
No documented SARS-CoV-2 infection
Mechanical ventilation
Known hypersensitivity to hydroxychloroquine or 4-aminoquinoline derivatives Preexisting retinopathy documented in medical history
Pregnancy or Breastfeeding
Concurrent use of any other quinine derivative (chloroquine, mefloquine) or rifamycins (rifampin, rifabutin)
